Titlebook: Gene Delivery and Therapy for Neurological Disorders; Xuenong Bo,Joost Verhaagen Book 2015 Springer Science+Business Media New York 2015 A

Tamoxifen

書目名稱Gene Delivery and Therapy for Neurological Disorders影響因子(影響力)




書目名稱Gene Delivery and Therapy for Neurological Disorders影響因子(影響力)學科排名




書目名稱Gene Delivery and Therapy for Neurological Disorders網(wǎng)絡(luò)公開度




書目名稱Gene Delivery and Therapy for Neurological Disorders網(wǎng)絡(luò)公開度學科排名




書目名稱Gene Delivery and Therapy for Neurological Disorders被引頻次




書目名稱Gene Delivery and Therapy for Neurological Disorders被引頻次學科排名




書目名稱Gene Delivery and Therapy for Neurological Disorders年度引用




書目名稱Gene Delivery and Therapy for Neurological Disorders年度引用學科排名




書目名稱Gene Delivery and Therapy for Neurological Disorders讀者反饋




書目名稱Gene Delivery and Therapy for Neurological Disorders讀者反饋學科排名

值得贊賞

reception

,Gene Therapy for Parkinson’s Disease: AAV5-Mediated Delivery of Glial Cell Line-Derived Neurotrophin identified as possible therapeutic molecule for the treatment of neurodegenerative diseases in several different animal models. Delivery of the GDNF has been proven to be very efficient using recombinant AAV vectors. AAV2 has been widely used for the delivery of transgenes to the brain and has eve

armistice

,Gene Delivery and Gene Therapy for Alzheimer’s Disease,efficiently confer long-term expression in a variety of cell types, but innovations including hybrid serotypes, rationally designed capsids, split vectors, specific promoter/enhancer additions, and convection-enhanced delivery have greatly progressed the field of AAV research for neurodegenerative d

Communicate

,Gene Therapy for Huntington’s Disease,psychiatric manifestations. The underlying genetic cause of HD is a mutation in the huntingtin gene resulting in an expanded polyglutamine tract in huntingtin protein that confers a toxic gain of function. Abnormal intranuclear protein inclusions and the progressive degeneration of medium spiny neur

反感

Gene Therapy Approaches to Promoting Axonal Regeneration After Spinal Cord Injury,nal cord injury and neural repair indicate that the two main obstacles that prevent successful axonal regeneration and functional recovery are the weak intrinsic regenerative capacity of the neurons and the presence of several types of inhibitory molecules in the central nervous system (CNS). Variou

反感

硬化

Targeted Gene Therapy for Ischemic Stroke,re are certain barriers in translating gene-based therapy to the clinical setting. For example, systemic delivery of genes into the brain is prevented by the blood–brain barrier (BBB); intraventricular delivery results in nonspecific distribution and gene expression; and stereotactic injection of ve

Keratectomy

FLIP